Literature DB >> 35723802

Reduced frequency of circulating regulatory T cells and their related immunosuppressive mediators in treated celiac patients.

Nastaran Asri1, Mohammad Rostami-Nejad2, Abdolrahim Nikzamir3, Elham Aghamohamadi4, Hamid Asadzadeh-Aghdaei4, Mohammad Reza Zali4.   

Abstract

BACKGROUND: Regulatory T cells (Tregs) have an important role in the control of the immune responses. This study aimed to compare the frequency of peripheral blood (PB) CD4+ CD25+ FoxP3+ Treg cells and PB and duodenal expression levels of pro- and anti-inflammatory mediators in treated celiac disease (CD) patients and healthy controls. METHODS AND
RESULTS: Duodenal biopsy specimens and PB samples were collected from 60 treated CD patients and 60 controls. Flow cytometry analysis was conducted on peripheral blood mononuclear cell (PBMC) specimens and relative PB and duodenal mRNA expression levels of CD25, forkhead box P3 (Foxp3), interleukin (IL)-10 and granzyme B (GrzB) were evaluated using quantitative real-time PCR. The levels of serum IL-10 and IL-6 were tested with sandwich enzyme-linked immunosorbent assay kits. p values < 0.05 were considered significant. Flow cytometry analysis showed a significant decrease in the number of Tregs in CD patients' PBMC specimens (p = 0.012). CD25 and Foxp3 PB mRNA expressions were also lower in CD patients without reaching the significance level (p > 0.05). IL-10 PB mRNA and protein expression did not differ between the groups (p > 0.05), and GrzB PB expression was significantly reduced in CD patients (p = 0.001). In duodenal specimens of CD patients, while significantly increased CD25, Foxp3 mRNA expression (p = 0.01 and 0.001, respectively) and decreased IL-10 mRNA expression (p = 0.02) were observed, GrzB mRNA expression did not differ between groups (p > 0.05). Moreover, a high serum level of IL-6 was observed in CD patients (p = 0.001).
CONCLUSIONS: Despite following the gluten free diet, there may still be residual inflammation in the intestine of CD patients. Accordingly, finding a therapeutic approach based on strengthening the function of Treg cells in CD might be helpful.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Autoimmunity; Celiac disease; Forkhead box protein 3; Gluten; Regulatory T cells; Transcription factor

Mesh:

Substances:

Year:  2022        PMID: 35723802     DOI: 10.1007/s11033-022-07674-w

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  37 in total

Review 1.  Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis.

Authors:  B Meresse; J Ripoche; M Heyman; N Cerf-Bensussan
Journal:  Mucosal Immunol       Date:  2008-10-29       Impact factor: 7.313

Review 2.  Celiac disease: prevalence, diagnosis, pathogenesis and treatment.

Authors:  Naiyana Gujral; Hugh J Freeman; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

Review 3.  Coeliac disease and gluten-related disorders in childhood.

Authors:  Sabine L Vriezinga; Joachim J Schweizer; Frits Koning; M Luisa Mearin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-23       Impact factor: 46.802

Review 4.  Celiac disease: understanding the gluten-free diet.

Authors:  Karla A Bascuñán; María Catalina Vespa; Magdalena Araya
Journal:  Eur J Nutr       Date:  2016-06-22       Impact factor: 5.614

Review 5.  Coeliac disease.

Authors:  Benjamin Lebwohl; David S Sanders; Peter H R Green
Journal:  Lancet       Date:  2017-07-28       Impact factor: 79.321

6.  Silent celiac disease is frequent in the siblings of newly diagnosed celiac patients.

Authors:  Maria Teresa Bardella; Luca Elli; Pietro Velio; Clara Fredella; Luigia Prampolini; Bruno Cesana
Journal:  Digestion       Date:  2007-09-11       Impact factor: 3.216

7.  Atypical celiac disease: from recognizing to managing.

Authors:  B Admou; L Essaadouni; K Krati; K Zaher; M Sbihi; L Chabaa; B Belaabidia; A Alaoui-Yazidi
Journal:  Gastroenterol Res Pract       Date:  2012-07-03       Impact factor: 2.260

Review 8.  Celiac disease: a comprehensive current review.

Authors:  Giacomo Caio; Umberto Volta; Anna Sapone; Daniel A Leffler; Roberto De Giorgio; Carlo Catassi; Alessio Fasano
Journal:  BMC Med       Date:  2019-07-23       Impact factor: 8.775

9.  Immunological reactions by T cell and regulation of crucial genes in treated celiac disease patients.

Authors:  Mohammad Rostami-Nejad; Zahra Razzaghi; Somayeh Esmaeili; Sina Rezaei-Tavirani; Alireza Akbarzadeh Baghban; Reza Vafaee
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2020

10.  Toward finding the difference between untreated celiac disease and COVID-19 infected patients in terms of CD4, CD25 (IL-2 Rα), FOXP3 and IL-6 expressions as genes affecting immune homeostasis.

Authors:  Nastaran Asri; Ehsan Nazemalhosseini Mojarad; Hamed Mirjalali; Seyed Reza Mohebbi; Kaveh Baghaei; Mohammad Rostami-Nejad; Abbas Yadegar; Mostafa Rezaei-Tavirani; Hamid Asadzadeh Aghdaei; Kamran Rostami; Andrea Masotti
Journal:  BMC Gastroenterol       Date:  2021-12-11       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.